Dana-Farber Brigham 天美传媒 is an internationally recognized leader in bladder cancer treatment and research. Our patients can expect to receive state-of-the-art care that is tailored to their unique needs. Our Center’s physicians have extensive experience in diagnosing and treating all types and stages of bladder cancer, including rare and complex cases. Thanks to our commitment to innovation, we provide breakthrough treatment options such as immunotherapy, precision medicine, and minimally invasive surgical techniques to improve outcomes and quality of life for our patients.
Additionally, as two top research hospitals, clinicians and researchers at Brigham and Women’s Hospital (BWH) and Dana-Farber Cancer Institute (DFCI) strive to enhance current treatments and explore novel approaches through clinical trials and “bench-to-bedside” research. Your care team will discuss with you the possibility of participating in clinical trials, which can provide additional options for treating your bladder cancer as well as a valuable opportunity to contribute to advancing treatment for bladder cancer.
What is bladder cancer?
Bladder cancer is a type of cancer that affects the bladder, a balloon shaped organ in the lower abdomen that stores urine. The bladder, with the help from the kidneys, remove toxins and waste from the body through urine. Bladder cancer is the fifth most common cancer in the United States, but it’s highly treatable in the early stages.
Types of bladder cancer:
- Transitional cell (urothelial) carcinoma: the most common type of bladder cancer, it occurs in 97% of diagnoses. It begins on the surface of the bladder’s inner lining.
- Squamous cell carcinoma: second most common type of bladder cancer. It begins in the thin, flat squamous cells that may form in the bladder after chronic inflammation or infection. Squamous cell carcinoma is more common in parts of the world where a parasitic infection called schistosomiasis is widespread.
More rare types of bladder cancer include adenocarcinoma and small cell carcinoma of the bladder, which account for one percent of all bladder cancers.
Learn more about .
